Clinical Trial Update: Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating ease of use, preference, and safety of EutropinPen Inject. in multiple pediatric indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Infant Small For Gestational Age
• Renal Failure
• Short Stature Idiopathic
• Turner Syndrome

Drugs mentioned

• EutropinPen Inject. (recombinant human growth hormone pen inject)

Snippet

Sponsor: LG Life Sciences | Conditions: Short Stature, Idiopathic, Infant, Small for Gestational Age | Phase 4 | Status: COMPLETED